RxDoctor Payments Data

Anna Mae Diehl, MD

Gastroenterology · Durham, NCNPI 1871512004

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $33,250 of the $36,140 with a category attached, or 92.0%. 7 manufacturers reported payments, led by Boehringer Ingelheim at 32.2% of the total. Reporting peaked in 2019 at $17,546 and has fallen 99.0% since, to $169 in 2024. Among gastroenterology clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$36,140in general payments, 2019–2025

Across 26 payments — averaging $1390.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$12K
  • Janssen Research & Development, LLC$10K
  • Merck$8K
  • Gilead$3K
  • Roche Diagnostics International Ltd$2K
  • Takeda Pharmaceuticals U.S.A., Inc.$1K
  • plus $98 from 1 others
$1,349,136in research payments, 2019–2025

Across 3 payments — averaging $449,712 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boehringer Ingelheim$1.3M

What the payments were for

  • Consulting fees$33,25092%
  • Speaking & faculty fees$890%
  • Travel & lodging$2,2876%
  • Food & beverage$5141%

General payments by program year

19
20
21
22
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$36,140 in reported general payments places this provider in the 90th percentile of 610 gastroenterology providers in North Carolina.

See all gastroenterology providers in North Carolina

Medicare billing

Part B allowed, 2024
$7,740
Medicare patients
50
Services billed
62

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gastroenterology in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →